Invasive Cardiology Unit, Humanitas Clinical and Research Center, IRCCS, Alessandro Manzoni, 56, 20089, Rozzano, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Curr Cardiol Rep. 2021 Aug 19;23(10):137. doi: 10.1007/s11886-021-01569-1.
Annular-based strategies for treating tricuspid valve (TV) regurgitation do not always have satisfactory long-term outcomes. Management of failed TV annuloplasty can be challenging and requires a dedicated heart team approach. This review explores the treatment options available for failed TV annuloplasty.
Recent developments and novel percutaneous treatment options have emerged as promising alternatives for patients with failed TV annuloplasty. Leaflet-based interventions, valve-in-valve procedures, transcatheter tricuspid valves and new-generation trans-caval valves are all feasible options, which can assure good results whilst minimizing risks for the patient. Failure of tricuspid annuloplasty is not uncommon amongst patients treated with either a tricuspid ring or suture-based device. The complex anatomy, physiology and clinical risk profile should be carefully evaluated on an individual patient-by-patient basis in order to select the most appropriate clinical and percutaneous treatment strategy. Different transcatheter tricuspid valve repair or replacement techniques may provide an attractive alternative treatment option for managing this challenging patient cohort.
目的:基于瓣环的三尖瓣反流(TR)治疗策略并不总是具有满意的长期结果。三尖瓣瓣环成形术失败的管理具有挑战性,需要专门的心脏团队方法。本综述探讨了三尖瓣瓣环成形术失败的治疗选择。
发现:最近的发展和新型经皮治疗选择已经成为三尖瓣瓣环成形术失败患者的有前途的替代方法。瓣叶介入、瓣中瓣手术、经导管三尖瓣置换和新一代经腔静脉瓣膜都是可行的选择,可以确保良好的结果,同时将患者的风险降到最低。在接受三尖瓣环或缝线装置治疗的患者中,三尖瓣瓣环成形术失败并不罕见。复杂的解剖、生理和临床风险特征应在个体患者的基础上进行仔细评估,以选择最合适的临床和经皮治疗策略。不同的经导管三尖瓣修复或置换技术可能为管理这一具有挑战性的患者群体提供有吸引力的替代治疗选择。